BIOREM INC (BRM.CA) Stock Fundamental Analysis

TSX-V:BRM • CA09068G1046

2.7 CAD
0 (0%)
Last: Feb 17, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

BRM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 25 industry peers in the Commercial Services & Supplies industry. BRM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BRM has a correct valuation and a medium growth rate. This makes BRM very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year BRM was profitable.
  • BRM had a positive operating cash flow in the past year.
  • In the past 5 years BRM has always been profitable.
  • Each year in the past 5 years BRM had a positive operating cash flow.
BRM.CA Yearly Net Income VS EBIT VS OCF VS FCFBRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M 3M 4M

1.2 Ratios

  • BRM has a better Return On Assets (7.60%) than 92.00% of its industry peers.
  • The Return On Equity of BRM (17.30%) is better than 88.00% of its industry peers.
  • BRM's Return On Invested Capital of 15.98% is amongst the best of the industry. BRM outperforms 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BRM is significantly above the industry average of 5.81%.
  • The 3 year average ROIC (25.13%) for BRM is well above the current ROIC(15.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 7.6%
ROE 17.3%
ROIC 15.98%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
BRM.CA Yearly ROA, ROE, ROICBRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

  • BRM has a better Profit Margin (6.08%) than 76.00% of its industry peers.
  • In the last couple of years the Profit Margin of BRM has grown nicely.
  • With a decent Operating Margin value of 8.87%, BRM is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • BRM's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 24.25%, BRM is in line with its industry, outperforming 48.00% of the companies in the same industry.
  • BRM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.87%
PM (TTM) 6.08%
GM 24.25%
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
BRM.CA Yearly Profit, Operating, Gross MarginsBRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRM is creating value.
  • The number of shares outstanding for BRM has been increased compared to 1 year ago.
  • Compared to 5 years ago, BRM has less shares outstanding
  • Compared to 1 year ago, BRM has an improved debt to assets ratio.
BRM.CA Yearly Shares OutstandingBRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BRM.CA Yearly Total Debt VS Total AssetsBRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • BRM has an Altman-Z score of 3.95. This indicates that BRM is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.95, BRM belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
  • BRM has a debt to FCF ratio of 1.39. This is a very positive value and a sign of high solvency as it would only need 1.39 years to pay back of all of its debts.
  • BRM's Debt to FCF ratio of 1.39 is amongst the best of the industry. BRM outperforms 96.00% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that BRM is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.20, BRM belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.39
Altman-Z 3.95
ROIC/WACC2.08
WACC7.68%
BRM.CA Yearly LT Debt VS Equity VS FCFBRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

  • BRM has a Current Ratio of 1.89. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BRM (1.89) is better than 88.00% of its industry peers.
  • BRM has a Quick Ratio of 1.73. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
  • BRM's Quick ratio of 1.73 is amongst the best of the industry. BRM outperforms 84.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.73
BRM.CA Yearly Current Assets VS Current LiabilitesBRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The earnings per share for BRM have decreased strongly by -64.28% in the last year.
  • BRM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.08% yearly.
  • Looking at the last year, BRM shows a very negative growth in Revenue. The Revenue has decreased by -24.88% in the last year.
  • The Revenue has been growing by 12.63% on average over the past years. This is quite good.
EPS 1Y (TTM)-64.28%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-47.19%
Revenue 1Y (TTM)-24.88%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-24.4%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.40% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 10.68% on average over the next years. This is quite good.
EPS Next Y5.26%
EPS Next 2Y21.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.42%
Revenue Next 2Y10.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BRM.CA Yearly Revenue VS EstimatesBRM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
BRM.CA Yearly EPS VS EstimatesBRM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.55 indicates a rather expensive valuation of BRM.
  • BRM's Price/Earnings ratio is a bit cheaper when compared to the industry. BRM is cheaper than 76.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.16, BRM is valued at the same level.
  • BRM is valuated reasonably with a Price/Forward Earnings ratio of 9.36.
  • BRM's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRM is cheaper than 96.00% of the companies in the same industry.
  • BRM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.10.
Industry RankSector Rank
PE 24.55
Fwd PE 9.36
BRM.CA Price Earnings VS Forward Price EarningsBRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 76.00% of the companies in the same industry are more expensive than BRM, based on the Enterprise Value to EBITDA ratio.
  • BRM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BRM is cheaper than 76.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.56
EV/EBITDA 10.64
BRM.CA Per share dataBRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRM does not grow enough to justify the current Price/Earnings ratio.
  • BRM has an outstanding profitability rating, which may justify a higher PE ratio.
  • BRM's earnings are expected to grow with 21.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.66
PEG (5Y)N/A
EPS Next 2Y21.4%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BRM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BIOREM INC

TSX-V:BRM (2/17/2026, 7:00:00 PM)

2.7

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-26
Earnings (Next)04-14
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners2%
Ins Owner ChangeN/A
Market Cap43.52M
Revenue(TTM)34.73M
Net Income(TTM)2.11M
Analysts84.44
Price Target3.57 (32.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.29%
Valuation
Industry RankSector Rank
PE 24.55
Fwd PE 9.36
P/S 1.25
P/FCF 19.56
P/OCF 16.93
P/B 3.57
P/tB 3.57
EV/EBITDA 10.64
EPS(TTM)0.11
EY4.07%
EPS(NY)0.29
Fwd EY10.68%
FCF(TTM)0.14
FCFY5.11%
OCF(TTM)0.16
OCFY5.91%
SpS2.15
BVpS0.76
TBVpS0.76
PEG (NY)4.66
PEG (5Y)N/A
Graham Number1.37
Profitability
Industry RankSector Rank
ROA 7.6%
ROE 17.3%
ROCE 21.09%
ROIC 15.98%
ROICexc 37.31%
ROICexgc 37.31%
OM 8.87%
PM (TTM) 6.08%
GM 24.25%
FCFM 6.41%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
ROICexc(3y)41.23%
ROICexc(5y)N/A
ROICexgc(3y)41.23%
ROICexgc(5y)N/A
ROCE(3y)33.17%
ROCE(5y)30.97%
ROICexgc growth 3Y-30.69%
ROICexgc growth 5YN/A
ROICexc growth 3Y-30.69%
ROICexc growth 5YN/A
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
F-Score4
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.39
Debt/EBITDA 0.67
Cap/Depr 66.81%
Cap/Sales 0.99%
Interest Coverage 250
Cash Conversion 71.47%
Profit Quality 105.47%
Current Ratio 1.89
Quick Ratio 1.73
Altman-Z 3.95
F-Score4
WACC7.68%
ROIC/WACC2.08
Cap/Depr(3y)93.69%
Cap/Depr(5y)79.96%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.28%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-47.19%
EPS Next Y5.26%
EPS Next 2Y21.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.88%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-24.4%
Revenue Next Year5.42%
Revenue Next 2Y10.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-59.97%
EBIT growth 3Y23.48%
EBIT growth 5YN/A
EBIT Next Year33.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.22%
FCF growth 3Y-3.66%
FCF growth 5Y6.73%
OCF growth 1Y-18.62%
OCF growth 3Y-0.86%
OCF growth 5Y7.83%

BIOREM INC / BRM.CA FAQ

What is the fundamental rating for BRM stock?

ChartMill assigns a fundamental rating of 7 / 10 to BRM.CA.


What is the valuation status of BIOREM INC (BRM.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to BIOREM INC (BRM.CA). This can be considered as Fairly Valued.


How profitable is BIOREM INC (BRM.CA) stock?

BIOREM INC (BRM.CA) has a profitability rating of 9 / 10.


What is the expected EPS growth for BIOREM INC (BRM.CA) stock?

The Earnings per Share (EPS) of BIOREM INC (BRM.CA) is expected to grow by 5.26% in the next year.